International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 3 , Pages 699-706 , 1 July 2010

PET CT Thresholds for Radiotherapy Target Definition in Non–Small-Cell Lung Cancer: How Close Are We to the Pathologic Findings?

Presented at the 50th American Society for Therapeutic Radiology and Oncology Annual Meeting, Boston, MA, September 21–24, 2008 and at the Canadian Association of Radiation Oncology Annual Scientific Meeting, Montreal, QB, Canada, September 10–13, 2008.

  • Kailiang Wu, M.D.

      Affiliations

    • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
    • Department of Radiotherapy, Cancer Hospital, Fudan University, Shanghai, China
    • ,
  • Yee C. Ung, M.D.

      Affiliations

    • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
    • Corresponding Author InformationReprint requests to: Yee C. Ung, M.D., F.R.C.P.C., Department of Radiotherapy, Odette Cancer Centre, 2075 Bayview Ave., Toronto, ON M4N 3M5 Canada. Tel: (416) 480-4951; Fax: (416) 480-6002
    • ,
  • Jennifer Hornby, B.Sc.

      Affiliations

    • Department of Thoracic Surgery, University of Toronto, Toronto, ON, Canada
    • ,
  • Marc Freeman, M.D.

      Affiliations

    • Department of Diagnostic Imaging, University of Toronto, Toronto, ON, Canada
    • ,
  • David Hwang, M.D.

      Affiliations

    • Department of Pathology, University of Toronto, Toronto, ON, Canada
    • ,
  • Ming S. Tsao, M.D.

      Affiliations

    • Department of Pathology, University of Toronto, Toronto, ON, Canada
    • ,
  • Max Dahele, M.B.Ch.B.

      Affiliations

    • University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
    • ,
  • Gail Darling, M.D.

      Affiliations

    • Department of Thoracic Surgery, University of Toronto, Toronto, ON, Canada
    • ,
  • Donna E. Maziak, M.D.

      Affiliations

    • Ottawa Regional Cancer Center, University of Ottawa, Ottawa, ON, Canada
    • ,
  • Romeo Tirona, B.Sc.

      Affiliations

    • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
    • ,
  • Kathy Mah, M.Sc.

      Affiliations

    • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
    • ,
  • C. Shun Wong, M.D.

      Affiliations

    • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada

Received 25 March 2009 ,Revised 21 May 2009 ,Accepted 26 May 2009.

References 

  1. Bradley JD, Ieumwananonthachai N, Purdy JA, et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non–small-cell lung carcinoma. Int J Radiat Oncol Biol Phys. 2002;52:49–57
  2. Willner J, Baier K, Caragiani E, et al. Dose, volume, and tumor control prediction in primary radiotherapy of non–small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002;52:382–389
  3. Rengan R, Rosenzweig KE, Venkatraman E, et al. Improved local control with higher doses of radiation in large-volume stage III non–small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;60:741–747
  4. Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:324–333
  5. Hicks RJ, Kalff V, MacManus MP, et al. (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med. 2001;42:1596–1604
  6. Gambhir SS, Czernin J, Schwimmer J, et al. A tabulated summary of the FDG PET literature. J Nucl Med. 2001;42:1S–93S
  7. Sasaki M, Ichiya Y, Kuwabara Y, et al. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: A comparative study with X-ray computed tomography. Eur J Nucl Med. 1996;23:741–747
  8. Langen KJ, Braun U, Rota Kops E, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med. 1993;34:355–359
  9. Black QC, Grills IS, Kestin LL, et al. Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys. 2004;60:1272–1282
  10. Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol. 2002;62:51–60
  11. Ashamalla H, Rafla S, Parikh K, et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys. 2005;63:1016–1023
  12. Mah K, Caldwell CB, Ung YC, et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non–small-cell lung carcinoma: A prospective study. Int J Radiat Oncol Biol Phys. 2002;52:339–350
  13. Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys. 2003;57:853–863
  14. van Der Wel A, Nijsten S, Hochstenbag M, et al. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non–small-cell lung cancer: A modeling study. Int J Radiat Oncol Biol Phys. 2005;61:649–655
  15. Kalff V, Hicks RJ, MacManus MP, et al. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non–small-cell lung cancer: A prospective study. J Clin Oncol. 2001;19:111–118
  16. Giraud P, Antoine M, Larrouy A, et al. Evaluation of microscopic tumor extension in non–small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 2000;48:1015–1024
  17. Chan R, He Y, Haque A, et al. Computed tomographic-pathologic correlation of gross tumor volume and clinical target volume in non-small cell lung cancer: A pilot experience. Arch Pathol Lab Med. 2001;125:1469–1472
  18. Stroom J, Blaauwgeers H, van Baardwijk A, et al. Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors. Int J Radiat Oncol Biol Phys. 2007;69:267–275
  19. Macpherson RE, Higgins GS, Murchison JT, et al. Non–small-cell lung cancer dimensions: CT-pathological correlation and interobserver variation. Br J Radiol. 2009;82:421–425
  20. Duhaylongsod FG, Lowe VJ, Patz EF, et al. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg. 1995;60:1348–1352
  21. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med. 1996;37:943–948
  22. Mastin ST, Drane WE, Harman EM, et al. FDG SPECT in patients with lung masses. Chest. 1999;115:1012–1017
  23. Halter G, Storck M, Guhlmann A, et al. FDG positron emission tomography in the diagnosis of peripheral pulmonary focal lesions. Thorac Cardiovasc Surg. 2000;48:97–101
  24. Ung YC, Maziak DE, Vanderveen JA, et al. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: A systematic review. J Natl Cancer Inst. 2007;99:1753–1767
  25. Price P. Molecular imaging to improve radiotherapy. Radiother Oncol. 2006;78:233–235
  26. Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;59:78–86
  27. Kiffer JD, Berlangieri SU, Scott AM, et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer. 1998;19:167–177
  28. Caldwell CB, Mah K, Ung YC, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non–small-cell lung tumors on CT: The impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys. 2001;51:923–931
  29. Erdi YE, Mawlawi O, Larson SM, et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer. 1997;80:2505–2509
  30. Nestle U, Kremp S, Schaefer-Schuler A, et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med. 2005;46:1342–1348
  31. Nestle U, Kremp S, Grosu AL. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol. 2006;81:209–225
  32. Dahele MR, Ung YC. 18F-FDG PET in planning radiation treatment of non-small cell lung cancer: Where exactly is the tumor?. J Nucl Med. 2007;48:1402
  33. Clarke GM, Eidt S, Sun L, et al. Whole-specimen histopathology: A method to produce whole-mount breast serial sections for 3-D digital histopathology imaging. Histopathology. 2007;50:232–342
  34. Dahele M, Hwang D, Peressotti C, et al. Developing a methodology for three-dimensional correlation of PET-CT images and whole-mount histopathology in non–small-cell lung cancer. Current Oncology. 2008;15:62–69
  35. Geets X, Daisne JF, Arcangeli S, et al. Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: Comparison between CT-scan and MRI. Radiother Oncol. 2005;77:25–31
  36. van Baardwijk A, Bosmans G, Boersma L, et al. PET-CT-based auto-contouring in non–small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys. 2007;68:771–778
  37. Steenbakkers RJ, Duppen JC, Fitton I, et al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: A “big brother” evaluation. Radiother Oncol. 2005;77:182–190
  38. Caldwell CB, Mah K, Skinner M, et al. Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET. Int J Radiat Oncol Biol Phys. 2003;55:1381–1393
  39. Jennings SG, Winer-Muram HT, Tann M, et al. Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements. Radiology. 2006;241:554–563

 Supported by the Ontario Cancer Research Network (OCRN) and Ontario Clinical Oncology Group (OCOG).

 Conflict of interest: none.

PII: S0360-3016(09)00791-3

doi: 10.1016/j.ijrobp.2009.05.028

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 3 , Pages 699-706 , 1 July 2010

Article Tools

* Image Usage & Resolution